Dr. Jacques A. Herzog, MD

Dr. Herzog practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Herzog's NPI, 1255330650, was assigned on July 18, 2005. Dr. Herzog graduated from University of Missouri, Kansas City, School of Medicine in 1980. Dr. Herzog holds Missouri license R7F68.

Dr. Herzog's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Herzog also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Herzog's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Herzog is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Herzog to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herzog practices, 6 sites in all. Vendor and product names are available with a free account.

Otology and neurotology is Dr. Herzog's primary specialty in the NPI Registry, under taxonomy code 207YX0901X. Dr. Herzog is licensed in Missouri.

CMS data shows 848 Medicare services from Dr. Herzog across 8 procedure codes in 2024, for 345 Medicare patients. Medicare paid $60,238 for them. Every service was in an office.

CMS counts 345 Medicare patients who saw Dr. Herzog in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Herzog's median patient age at 70, with 55% women.

In 2024, Dr. Herzog wrote 700 Medicare Part D claims for 266 patients. 94% of them were for generic drugs. CMS names the drug for 629 of them, across 15 drugs with 11 or more claims each, at $15,863 in total drug cost. In 2023, CMS named 700 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Herzog for performance year 2024, reported as part of a group. Dr. Herzog accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 42 papers to Dr. Herzog, published from 2017 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Cochlear Implantation, Cochlear Implants and Speech Perception. Dr. Herzog has published most often in Otol Neurotol. Dr. Herzog's most frequent co-authors are Craig Alan Buchman, MD, Nedim Durakovic, MD and Amit Walia, MD.

Dmand AI links Dr. Herzog to 5 clinical trials. Conditions studied include Hearing Loss, Sensorineural, Hearing Loss and Hearing Loss, Bilateral. Cochlear sponsors the most, 4.

CMS Open Payments shows 184 general payments to Dr. Herzog from 14 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 53% of the total. Cochlear Ltd paid the most, $90,275. It also lists 5 research payments totaling $1,287 from 2018 to 2019.

Dr. Herzog graduated from University of Missouri, Kansas City, School of Medicine in 1980.